Cancer Nanotechnology operates a single-blind peer-review system, where the reviewers are aware of the names and affiliations of the authors, but the reviewer reports provided to authors are anonymous Publication of research articles by Cancer Nanotechnology is dependent primarily on their scientific validity and coherence as judged by our external expert editors and/or peer reviewers, who will also assess whether the writing is comprehensible and whether the work represents a useful contribution to the field.
Submitted manuscripts will generally be reviewed by two to three experts who will be asked to evaluate whether the manuscript is scientifically sound and coherent, whether it duplicates already published work, and whether or not the manuscript is sufficiently clear for publication. Reviewers will also be asked to indicate how interesting and significant the research is. The Editors will reach a decision based on these reports and, where necessary, they will consult with members of the Editorial Board.
2018 Journal Metrics
52 days to first decision for reviewed manuscripts only
47 days to first decision for all manuscripts
160 days from submission to acceptance
23 days from acceptance to publication
52 Altmetric mentions
- ISSN: 1868-6966 (electronic)
- ISSN: 1868-6958 (print)